Olema Oncology Appoints Jason O’Byrne as CFO
Olema Oncology (Nasdaq: OLMA) appointed Jason O’Byrne, MBA, as Chief Financial Officer, effective as the company approaches pivotal…
CERAN wrap: Roche phase III BC win seals thesis, boosts Olema
Roche AG’s Genentech unit landed another clinical victory with giredestrant that provided a major stock boost for competitor…